Middle East Healthcare Reports SAR 25.7M Net Profit in Three Months 2026
SAUDI GERMAN HEALTH 4009.SA | 0.00 |
On 2026-05-03 16:26:32 (Saudi Time), Middle East Healthcare Co. announced its Interim financial results for the three months ended on March 31, 2026.
| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 765.23 | 733.57 | 4.315 | 808.77 | -5.383 |
| Gross Profit (Loss) | 254.27 | 279.98 | -9.182 | 277 | -8.205 |
| Operational Profit (Loss) | 80.04 | 221.65 | -63.889 | 91.24 | -12.275 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 25.7 | 160.13 | -83.95 | 37.79 | -31.992 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 25.8 | 160.1 | -83.885 | 29.22 | -11.704 |
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Total Shareholders Equity (after Deducting Minority Equity) | 1,898.17 | 1,786.2 | 6.268 |
| Profit (Loss) per Share | 0.28 | 1.74 | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
Year-on-Year Performance Drivers
Sales increased 4.315% YoY to SAR 765.23 million driven by growth in inpatient and outpatient visits and ramp-up of subspecialty services enhancing service mix and case complexity. Net profit declined 83.95% YoY to SAR 25.7 million primarily due to the previous year including a non-recurring capital gain of SAR 114 million from land sale, impact of NPHIES fees on Ministry of Health revenues, and share of losses from a minority-owned investee that commenced operations in Q4 2025.
Quarter-on-Quarter Performance Drivers
QoQ revenue declined 5.383% to 765.23 million due to seasonality impact from full alignment of Ramadan and Eid Al-Fitr within the current quarter. Net profit dropped 31.992% to 25.7 million primarily driven by the seasonal revenue decline and increased operating costs from activation of new subspecialty services.
Other Items
The external auditor issued an unmodified conclusion with an emphasis of matter paragraph drawing attention to Note 16 regarding transactions and balances with related parties provided by entities under common control. Total shareholders equity increased 6.268% to SAR 1,898.17 million. The company early adopted IFRS 18 and holds a 22.41% stake in an associate company that commenced operations in Q4 2025, with Middle East Healthcare's share of the associate's loss amounting to SAR 7 million during Q1 2026.
Original announcement:
https://www.saudiexchange.sa/wps/portal/saudiexchange/newsandreports/issuer-news/issuer-announcements/issuer-announcements-details/?anId=94901&anCat=1&cs=4009&locale=arImportant Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.